S Namba

Risk factors for the development of glucocorticoid-induced diabetes mellitus

Takayuki Katsuyama, Ken‐ei Sada, S Namba et al. · Diabetes Research and Clinical Practice · 2015 · 80 citations

Obesity, Metabolic Syndrome, Diabetes +6

Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation

S Namba, Minako Yamaoka‐Tojo, Ryota Kakizaki et al. · Heart and Vessels · 2017 · 51 citations

Thrombosis, Cardiovascular Disease, Atherosclerosis +15

Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-<i>κ</i>B Pathway

Takehiro Hashikata, Minako Yamaoka‐Tojo, S Namba et al. · International Heart Journal · 2015 · 50 citations · Full text

Cardiac Muscle, Heart Failure, Immunology +19

Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis

S Namba, Minako Yamaoka‐Tojo, Takehiro Hashikata et al. · BBA Clinical · 2015 · 42 citations · Full text

Stimulation of Internal Capsule, Thalamic Sensory Nucleus (VPM) and Cerebral Cortex Inhibited Deafferentation Hyperactivity Provoked After Gasserian Ganglionectomy in Cat

S Namba, Akira Nishimoto · 1988 · 40 citations